Cargando…
Factors Driving Patient Preferences for Growth Hormone Deficiency (GHD) Injection Regimen and Injection Device Features: A Discrete Choice Experiment
INTRODUCTION: The daily injection burden of recombinant human growth hormone (r-hGH) replacement therapy to treat growth hormone deficiency (GHD) may reduce compliance and limit treatment benefit. Research is needed to evaluate patient preferences for GHD injection regimen and device features. OBJEC...
Autores principales: | McNamara, Michelle, Turner-Bowker, Diane M, Westhead, Hal, Yaworsky, Andrew, Palladino, Andrew, Gross, Hillary, Pleil, Andy, Loftus, Jane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7198440/ https://www.ncbi.nlm.nih.gov/pubmed/32431492 http://dx.doi.org/10.2147/PPA.S239196 |
Ejemplares similares
-
Development and Psychometric Evaluation of the Life Interference Questionnaire for Growth Hormone Deficiency (LIQ-GHD) to Assess Growth Hormone Injection Burden in Children and Adults
por: Turner-Bowker, Diane M., et al.
Publicado: (2020) -
Experience of switching from a daily to a less frequent administration of injection treatments
por: Loftus, Jane, et al.
Publicado: (2022) -
Physician experience with once-weekly somatrogon versus once-daily rhGH regimen in pediatric patients with growth hormone deficiency: a cross-sectional survey of physicians from the global phase 3 study
por: Gomez, Roy, et al.
Publicado: (2023) -
Patient Preferences for Injectable Treatments for Multiple Sclerosis in the United States: A Discrete-Choice Experiment
por: Poulos, Christine, et al.
Publicado: (2015) -
Patient Preference for Self-Injection Devices in Rheumatoid Arthritis: A Discrete Choice Experiment in China
por: Wei, Yan, et al.
Publicado: (2022)